Literature DB >> 2291988

Improvement of pneumonia and arthritis in Felty's syndrome by treatment with granulocyte-macrophage colony-stimulating factor (GM-CSF).

A S Lübbe1, N Schwella, H Riess, D Huhn.   

Abstract

A 63-year old man with Felty's syndrome and pneumonia of unknown origin was treated with GM-CSF. Granulocyte counts increased and arthritis-related symptoms improved under GM-CSF. Pneumonia was treated effectively with antibiotics only during or after GM-CSF application. This suggests, that antibiotic-resistant infections can be treated effectively in patients with Felty's syndrome when granulocyte counts are raised by GM-CSF.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2291988     DOI: 10.1007/bf01738554

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  4 in total

1.  Severe neutropenia associated with large granular lymphocyte lymphocytosis: successful control with cyclosporin A.

Authors:  E Pastor; M J Sayas
Journal:  Blut       Date:  1989-12

Review 2.  The granulocyte-macrophage colony-stimulating factors.

Authors:  D Metcalf
Journal:  Science       Date:  1985-07-05       Impact factor: 47.728

Review 3.  The granulocyte-macrophage colony stimulating factors.

Authors:  D Metcalf
Journal:  Cell       Date:  1985-11       Impact factor: 41.582

4.  Correction of granulocytopenia in Felty's syndrome by granulocyte-macrophage colony-stimulating factor. Simultaneous induction of interleukin-6 release and flare-up of the arthritis.

Authors:  B P Hazenberg; M A Van Leeuwen; M H Van Rijswijk; A C Stern; E Vellenga
Journal:  Blood       Date:  1989-12       Impact factor: 22.113

  4 in total
  4 in total

1.  Treatment of neutropenia in Felty's syndrome with granulocyte-macrophage colony-stimulating factor--hematological response accompanied by pulmonary complications with lethal outcome.

Authors:  A R Gari-Bai; C Rochlitz; M Riewald; J Oertel; D Huhn
Journal:  Ann Hematol       Date:  1992-11       Impact factor: 3.673

2.  Felty's syndrome treated with rhG-CSF associated with flare of arthritis and skin rash.

Authors:  M F McMullin; M B Finch
Journal:  Clin Rheumatol       Date:  1995-03       Impact factor: 2.980

3.  Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF) : A Review of its Pharmacological Properties and Prospective Role in the Management of Myelosuppression.

Authors:  Susan M Grant; Rennie C Heel
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

4.  Successful treatment of chronic wound infection in neutropenia and rheumatoid arthritis with filgrastim (rhG-GSF)

Authors:  J Fohlman; M Höglund; S Bergmann
Journal:  Ann Hematol       Date:  1994-09       Impact factor: 3.673

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.